---
title: "TD Cowen Reaffirms Their Buy Rating on United Therapeutics (UTHR)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286711472.md"
description: "TD Cowen analyst Joseph Thome has reaffirmed a Buy rating on United Therapeutics (UTHR) with a price target of $675.00. Thome, who focuses on the Healthcare sector, has an average return of 21.7% and a 55.38% success rate. Additionally, Wells Fargo also issued a Buy rating for UTHR, while Oppenheimer assigned a Hold rating on May 11."
datetime: "2026-05-18T03:55:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286711472.md)
  - [en](https://longbridge.com/en/news/286711472.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286711472.md)
---

# TD Cowen Reaffirms Their Buy Rating on United Therapeutics (UTHR)

In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on United Therapeutics, with a price target of $675.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Thome covers the Healthcare sector, focusing on stocks such as United Therapeutics, Viridian Therapeutics, and Xenon. According to TipRanks, Thome has an average return of 21.7% and a 55.38% success rate on recommended stocks.

In addition to TD Cowen, United Therapeutics also received a Buy from Wells Fargo’s Benjamin Burnett in a report issued on May 7. However, on May 11, Oppenheimer assigned a Hold rating to United Therapeutics (NASDAQ: UTHR).

### Related Stocks

- [UTHR.US](https://longbridge.com/en/quote/UTHR.US.md)
- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)
- [XENE.US](https://longbridge.com/en/quote/XENE.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [OPY.US](https://longbridge.com/en/quote/OPY.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Ameritas Advisory Services LLC Boosts Stake in United Therapeutics Corporation $UTHR](https://longbridge.com/en/news/286373098.md)
- [United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026 | UTHR Stock News](https://longbridge.com/en/news/286679932.md)
- [United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 10,000 Shares](https://longbridge.com/en/news/286643771.md)
- [Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease | UTHR Stock News](https://longbridge.com/en/news/286236984.md)
- [United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial | UTHR Stock News](https://longbridge.com/en/news/286620202.md)